Evanston Advisors’s General Moly, Inc. GMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$43K Buy
190,000
+7,600
+4% +$1.73K 0.01% 62
2018
Q3
$67K Buy
182,400
+4,100
+2% +$1.6K 0.01% 71
2018
Q2
$73K Buy
178,300
+28,300
+19% +$11.2K 0.02% 69
2018
Q1
$57K Buy
150,000
+25,000
+20% +$9.79K 0.01% 66
2017
Q4
$41K Sell
125,000
-25,000
-17% -$7.96K 0.01% 66
2017
Q3
$56K Hold
150,000
0.01% 65
2017
Q2
$55K Buy
150,000
+2,600
+2% +$892 0.01% 67
2017
Q1
$74K Buy
+147,400
New +$70.9K 0.02% 60

Other funds holding GMO

Evanston Advisors's GMO Position: Q4 2018 in Review

Evanston Advisors increased its General Moly, Inc. (GMO) stake by 4.2% in Q4 2018, buying an estimated $1.73K and bringing the position to 190,000 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #62.

Evanston Advisors first reported a position in GMO in Q1 2017 and has held it in 8 quarters since. The position peaked at $74K in Q1 2017. 38 funds tracked by Wall St. Rank hold GMO as of Q4 2018.

  • Evanston Advisors held 190,000 shares of General Moly, Inc. worth $43K as of Q4 2018.
  • Evanston Advisors bought 7,600 General Moly, Inc. shares in Q4 2018, an estimated $1.73K.
  • General Moly, Inc. made up 0.01% of Evanston Advisors's portfolio in Q4 2018, its #62 holding.
  • Evanston Advisors first reported a position in General Moly, Inc. in Q1 2017 and has held it in 8 quarters since.
  • Evanston Advisors's General Moly, Inc. position peaked at $74K in Q1 2017.
  • 38 funds tracked by Wall St. Rank held General Moly, Inc. as of Q4 2018.

Based on Evanston Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.